What's New at Charles River
   
 
 
   
   

Expert Safety Testing to Accelerate Your Cell Therapy Development

May 11, 2012 - Charles River's unique portfolio of services, including discovery, preclinical, biopharmaceutical testing, cell detection methods, specialized and unique models, and regulatory guidance, provides the full spectrum of resources needed to conduct a successful cell therapy safety program.

Custom Study Designs

Charles River assists clients in developing cellular therapies using a strategic and consultative approach. With great consideration given to regulatory expectations, our customized cellular therapy programs integrate both safety and efficacy endpoints as well as mitigate risk factors inherent to developing novel cellular therapies. In the design of your program, our multidisciplinary team will incorporate the novel properties of your cellular product, including considerations of cross-species reactivity, animal model selection and development of validated translational biomarkers.

For more information about how Charles River can support and accelerate your cell therapy development, please contact us at askcharlesriver@crl.com.


Related Information

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 13 - High-Throughput Screening for CNS ...
May 08 - Comparability Studies for Monoclon...
May 28-Jun 01 - Kobe, Japan - Joint Meeting of the International Bone and Mineral Socie...
May 23-May 23 - East Lansing, Michigan, USA - The Ins and Outs of Transgenic Colongy Ma...

Charles River Laboratories, Inc.